SK is a South Korean industrial conglomerate active in energy, chemicals, telecommunications, semiconductors, biopharmaceuticals, and trading services industries
Business Model:
Revenue: $75.2B
Employees: 10,001-999,999
Address: 26, Jong-ro, Jongno-gu
City: Seoul
State: seoul teugbyeolsi
Zip: 03188
Country: KR
SK is a South Korean industrial conglomerate active in energy, chemicals, telecommunications, semiconductors, biopharmaceuticals, and trading services industries
Contact Phone:
Contact Email:
Listed Exchange:
Korea Exchange
IPO Date:
11/11/2009
Ticker Symbol:
034730
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2018 | Lingbao Wason Copper Foil | Corporate Round | 238.6M |
12/2021 | Halio | Series D | 0 |
7/2021 | Nature’s Fynd | Series C | 0 |
4/2018 | Socar | Series C | 56.1M |
11/2020 | Testworks | Series B | 0 |
12/2018 | GenEdit | Seed Round | 8.5M |
1/2022 | Center for Breakthrough Medicines | Corporate Round | 0 |
12/2021 | Fulcrum Bioenergy | Venture Round | 0 |
12/2019 | Hummingbird Bioscience | Series B | 0 |
7/2017 | ESR | Corporate Round | 333.3M |
11/2022 | Wildtype | Corporate Round | 7.5M |
12/2021 | Palm NFT Studio | Series B | 0 |
4/2021 | SES | Series D | 0 |
5/2020 | Enuma | Series B | 0 |
4/2021 | Polestar | Private Equity Round | 0 |
3/2020 | Harbour Biomed | Series B | 75M |
9/2021 | Perfect Day | Series D | 0 |
4/2020 | Otonomo | Series C | 0 |
5/2021 | Hummingbird Bioscience | Series C | 0 |
9/2021 | GenEdit | Series A | 0 |
9/2017 | Turo | Series D | 104M |
7/2020 | Lingbao Wason Copper Foil | Corporate Round | 83.1M |
11/2019 | Standigm | Corporate Round | 7.2M |
1/2019 | Halio | Series D | 100M |
1/2022 | Center for Breakthrough Medicines | Corporate Round | 0 |
12/2021 | Fulcrum Bioenergy | Venture Round | 0 |
12/2021 | Palm NFT Studio | Series B | 0 |
12/2021 | Halio | Series D | 0 |
9/2021 | Perfect Day | Series D | 0 |
9/2021 | GenEdit | Series A | 0 |
7/2021 | Nature’s Fynd | Series C | 0 |
5/2021 | Hummingbird Bioscience | Series C | 0 |
4/2021 | SES | Series D | 0 |
4/2021 | Polestar | Private Equity Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2015 | Unattributed | $25M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|